Hansson L
University of Gothenburg, Department of Medicine, Ostra Hospital, Sweden.
J Hum Hypertens. 1989 Jun;3 Suppl 1:97-100.
Although there is no obvious pharmacological rationale for the combined use of an ACE inhibitor and a beta-blocker in the treatment of hypertension, this combination has proved to be more effective than monotherapy in a number of studies, some of which are reviewed. Moreover, there is evidence that this combination may be beneficial after myocardial infarction. Combined use of ACE inhibitor and beta-blocker therapy therefore warrants further investigation.
尽管在高血压治疗中联合使用血管紧张素转换酶(ACE)抑制剂和β受体阻滞剂没有明显的药理学依据,但在多项研究中已证明这种联合用药比单一疗法更有效,本文对其中一些研究进行了综述。此外,有证据表明这种联合用药在心肌梗死后可能有益。因此,ACE抑制剂和β受体阻滞剂联合治疗值得进一步研究。